Food & Drug Administration (FDA)

Consumer Fraud Corporate Fraud Federal Drug Administration (FDA) Health Care Fraud Indiana Medication Fraud Our Daily News US Department of Justice (DOJ)

Former CEO Sentenced to Prison for Defrauding Food and Drug Administration and Distributing Adulterated Drugs

Department of Justice Office of Public Affairs FOR IMMEDIATE RELEASE Thursday, September 19, 2019 The former president of a drug compounding company was sentenced to prison for his convictions for conspiring to defraud the Food and Drug Administration (FDA) and for multiple counts of distributing adulterated drugs, the Department of Justice announced today. U.S. District […]

Advertisements

District Court Orders Tennessee Companies and Their Owner to Stop Distributing Unapproved New Drugs and Misbranded and Adulterated Dietary Supplements

District Court Orders Texas Company to Stop Selling Adulterated Food

Inside the labs creating meat from stem cells – CBS News

Medical Device Company Pleads Guilty and is Sentenced to Pay $3 Million for Failure to Report a Recall United States v. ACell, Inc.

Medical Device Maker ACell Inc. Pleads Guilty and Will Pay $15 Million to Resolve Criminal Charges and Civil False Claims Allegations

Advertisements
Advertisements

FDA Press Releases

RSS FDA Press Releases RSS Feed
Advertisements
Advertisements

Recalls

RSS Food and Drugs Administration–Recalls/Safety Alerts
Advertisements
Advertisements

Criminal Investigations Press Releases

RSS Office of Criminal Investigations (OCI) Press Releases RSS Feed

Food Allergy

RSS Food Allergies

MedWatch Safety Alerts

RSS MedWatch Safety Alerts RSS Feed

Enforcement
Reports

RSS Food and Drug Administration–Enforcement Report

Consumer Health Information Updates

RSS Consumer Updates RSS Feed
  • Treating and Preventing Head Lice January 17, 2020
    Head lice. Learn how to check for them, how to treat them, and how to avoid having them in your home.
    FDA
  • You May Be Surprised by How Much Salt You're Eating January 13, 2020
    FDA is encouraging industry to gradually reduce the amount of sodium in foods. Consumers have the opportunity to comment.
    FDA
  • Is It a Cold or the Flu? Prevention, Symptoms, Treatments January 3, 2020
    In much of the Northern Hemisphere, this is prime time for colds, influenza (flu), and other respiratory illnesses. While contagious viruses are active year-round, most infections occur in the fall and winter.
    FDA
  • Los adolescentes y los esteroides, una combinación peligrosa December 26, 2019
    Los esteroides anabólicos son especialmente peligrosos para los adolescentes, cuyos cuerpos aún están en desarrollo. En algunos casos, el daño puede ser irreversible.
    FDA
  • FDA Acts to Prevent More Drug Shortages December 26, 2019
    A new strategic plan and proposed new rule aim to prevent shortages of critical drugs and biologics.
    FDA
  • La FDA actúa para prevenir más casos de escasez de medicamentos December 26, 2019
    Un nuevo plan estratégico y la propuesta de una nueva regla aspiran a prevenir la escasez de medicamentos y productos biológicos cruciales.
    FDA
  • ¿Por qué las carnazas de carne seca están enfermando a las mascotas? December 26, 2019
    Miles de perros y algunos gatos en los Estados Unidos se han enfermado después de comer carnazas (tiras o palitos de carne seca) para mascotas. A pesar de investigaciones exhaustivas, la causa aún se desconoce. Los científicos de la FDA están ampliando la búsqueda de la causa solicitando muestras e información a los consumidores y […]
    FDA
  • Why Are Jerky Treats Making Pets Sick? December 26, 2019
    Thousands of dogs and some cats in the U.S. have gotten sick after eating jerky pet treats. Despite extensive investigations, the cause remains elusive. FDA scientists are broadening the search for the cause by soliciting samples and information from consumers and veterinarians.
    FDA
  • Hyperbaric Oxygen Therapy: Don't Be Misled December 26, 2019
    Hyperbaric Oxygen Therapy has not been proven to cure cancer, autism, or diabetes. But advertising on the Internet would have you believe it'sa cure-all for many diseases. Using HBOT in the absence of other treatments can endanger your health. Read the Consumer update to learn more.
    FDA
  • Babies Spitting Up—Normal in Most Cases December 26, 2019
    If your baby is spitting up all the time, does it signal a more serious illness? Is medicine called for? Learn how to tell the difference between normal behavior and cause for concern, and what to do in each case.
    FDA

What's New: Drugs

RSS What's New: Drugs RSS Feed
  • MedWatch: The FDA Safety Information and Adverse Event Reporting Program January 24, 2020
    MedWatch is made up of voluntary and mandatory reporting on prescription medicines, over-the-counter medicines, non-vaccine biologicals, medical devices, special nutritional products, cosmetics and non-prescription human drug products marketed without an approved application.
    FDA
  • Drug Trial Snapshot: AYVAKIT January 24, 2020
    AYVAKIT is used to treat adult patients with gastrointestinal stromal tumor (GIST) whose disease: is caused by certain abnormal platelet-derived growth factor receptor alpha (PDGFRA) genes and, cannot be surgically removed or, has spread throughout the body (metastatic GIST).
    FDA
  • On Demand Webinar: Recent Revisions to the ANDA Prioritization MAPP – Jan. 2020 January 24, 2020
    The FDA offers priority review to abbreviated new drug applications (ANDAs) that may have meaningful impact on generic drug access. Priority review means that FDA gives an ANDA submission either (1) a shorter goal date, or (2) an expedited review. For an ANDA submission to be eligible for priority r
    FDA
  • FDA approves tazemetostat for advanced epithelioid sarcoma January 24, 2020
    Oncology News Burst
    FDA
  • What's New Related to Drugs January 24, 2020
    Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.
    FDA
  • Webinar: Submitting IND Safety Reports to FDA Adverse Event Reporting System (FAERS)- Nov. 1, 2019 January 24, 2020
    FDA is establishing a new submission process for investigational new drug (IND) safety reports. Submission of this important safety information as structured data will improve FDA’s ability to review and track safety signals that occur during the conduct of clinical trials. It will also provide spon
    FDA
  • MCM-Related Guidance by Date January 24, 2020
    Guidances and other information of special interest to MCM stakeholders, sponsors and applicants, listed by date
    FDA
  • Drug Trials Snapshots January 24, 2020
    Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent. Drug Trials Snapshots provide consumers with information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots […]
    FDA
  • Newly Added Guidance Documents January 24, 2020
    Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.
    FDA
  • Hematologic Malignancies: Regulatory Considerations for Use of Minimal Residual Disease in Development of Drug and Biological Products for Treatment January 24, 2020
    Assist sponsors planning to use minimal residual disease (MRD) as a biomarker in clinical trials conducted under an investigational new drug application (IND) or to 19 support marketing approval of drugs and biological products2 for the treatment of specific 20 hematologic malignancies.
    FDA
Advertisements
Advertisements

Office of Regulatory Affairs (ORA) FOIA Electronic Reading Room

RSS ORA FOIA Electronic Reading Room RSS Feed
Advertisements
Advertisements
Advertisements